JACQUELINE HELMUS: Open Payments
NPI 1902663727 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,801 in 126 payments from 38 companies in 2025. Trend: 2023 $0 · 2024 $2,517 · 2025 $2,801
Food & beverage: $2,801
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $290 |
| Janssen Biotech, Inc. | 11 | $219 |
| Gilead Sciences, Inc. | 9 | $211 |
| Merck Sharp & Dohme LLC | 9 | $206 |
| Novartis Pharmaceuticals Corporation | 8 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 5 | $98 |
| Geron Corporation | 4 | $96 |
| Celgene Corporation | 3 | $94 |
| GlaxoSmithKline, LLC. | 4 | $85 |
Products named: Trodelvy, KEYTRUDA, IMFINZI, RYBREVANT, Nubeqa, OPDIVO, RYTELO, REBLOZYL.
Industry payments across FL — which companies pay providers there.
